» Articles » PMID: 29370428

The Effect of High-volume Online Haemodiafiltration on Nutritional Status and Body Composition: the ProtEin Stores PrEservaTion (PESET) Study

Abstract

Background: Compared with conventional haemodialysis (HD), online haemodiafiltration (OL-HDF) achieves a more efficient removal of uraemic toxins and reduces inflammation, which could favourably affect nutritional status. We evaluate the effect of OL-HDF on body composition and nutritional status in prevalent high-flux HD (HF-HD) patients.

Methods: In all, 33 adults with chronic kidney disease (CKD) Stage 5 undergoing maintenance HF-HD were assigned to post-dilution OL-HDF (n = 17) or to remain on HF-HD (n = 16, control group) for 12 months. The primary outcome was the change in lean tissue mass (LTM), intracellular water (ICW) and body cell mass (BCM) assessed by multifrequency bioimpedance spectroscopy (BIS) at baseline and 4, 8 and 12 months. The rate of change in these parameters was estimated with linear mixed-effects models.

Results: Compared with OL-HDF, patients assigned to HF-HD experienced a gradual reduction in LTM, ICW and BCM. These differences reached statistical significance at Month 12, with a relative difference of 7.31 kg [95% confidence interval (CI) 2.50-12.11; P = 0.003], 2.32 L (95% CI 0.63-4.01; P = 0.008) and 5.20 kg (95% CI 1.74-8.66; P = 0.004) for LTM, ICW and BCM, respectively. The normalized protein appearance increased in the OL-HDF group compared with the HF-HD group [0.26 g/kg/day (95% CI 0.05-0.47); P = 0.002], with a relative reduction in high-sensitive C-reactive protein [-13.31 mg/dL (95% CI -24.63 to -1.98); P = 0.02] at Month 12.

Conclusions: OL-HDF for 1 year compared with HF-HD preserved muscle mass, increased protein intake and reduced the inflammatory state related to uraemia and dialysis, supporting the hypothesis that high convection volume can benefit nutritional status and prevent protein-energy wasting in HD patients.

Citing Articles

Body Composition and Intradialytic Exercise in Kidney Disease: A Combined Analysis of the PEDAL and CYCLE-HD Randomised Controlled Trials.

Ng K, Macdonald J, Young R, March D, Graham-Brown M, Mercer T J Cachexia Sarcopenia Muscle. 2025; 16(2):e13748.

PMID: 40026059 PMC: 11873537. DOI: 10.1002/jcsm.13748.


The Janus-faced nature of complement in hemodialysis: interplay between complement, inflammation, and bioincompatibility unveiling a self-amplifying loop contributing to organ damage.

Canaud B, Stenvinkel P, Scheiwe R, Steppan S, Bowry S, Castellano G Front Nephrol. 2024; 4:1455321.

PMID: 39691704 PMC: 11649546. DOI: 10.3389/fneph.2024.1455321.


Hemoincompatibility in Hemodialysis-Related Therapies and Their Health Economic Perspectives.

Hornig C, Bowry S, Kircelli F, Kendzia D, Apel C, Canaud B J Clin Med. 2024; 13(20).

PMID: 39458115 PMC: 11509023. DOI: 10.3390/jcm13206165.


Does Dietary Intake Differ in Kidney Failure Patients With Sarcopenia and Frailty Treated by Hemodialysis.

Shaaker H, Davenport A Gerontol Geriatr Med. 2024; 10:23337214241253433.

PMID: 38765918 PMC: 11100388. DOI: 10.1177/23337214241253433.


Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond.

Pedreros-Rosales C, Jara A, Lorca E, Mezzano S, Pecoits-Filho R, Herrera P Toxins (Basel). 2023; 15(9).

PMID: 37755957 PMC: 10535648. DOI: 10.3390/toxins15090531.